U
MGCD

UBS’s MGC Diagnostics Corporation MGCD Stock Holding History

UBS’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$5K Sell
773
-1,176
-60% -$9.11K ﹤0.01% 9536
2014
Q2 		$16K Sell
1,949
-8,421
-81% -$83.3K ﹤0.01% 8387
2014
Q1 		$118K Sell
10,370
-2,283
-18% -$25.8K ﹤0.01% 5794
2013
Q4 		$161K Buy
12,653
+11,897
+1,574% +$145K ﹤0.01% 5529
2013
Q3 		$8K Buy
+756
New +$6.79K ﹤0.01% 9055

Other funds holding MGCD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HIP
Hatteras Investment Partners Raleigh, North Carolina $169K AUM 86.49% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS's MGCD Position: Q3 2014 in Review

UBS reduced its MGC Diagnostics Corporation (MGCD) stake by 60% in Q3 2014, selling an estimated $9.11K and leaving 773 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #9536.

UBS first reported a position in MGCD in Q3 2013 and has held it in 5 quarters since. The position peaked at $161K in Q4 2013. 17 funds tracked by Wall St. Rank hold MGCD as of Q3 2014.

  • UBS held 773 shares of MGC Diagnostics Corporation worth $5K as of Q3 2014.
  • UBS sold 1,176 MGC Diagnostics Corporation shares in Q3 2014, an estimated $9.11K.
  • MGC Diagnostics Corporation made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9536 holding.
  • UBS first reported a position in MGC Diagnostics Corporation in Q3 2013 and has held it in 5 quarters since.
  • UBS's MGC Diagnostics Corporation position peaked at $161K in Q4 2013.
  • 17 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.